SABS
SAB Biotherapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C+
Company Profile
CEO
Samuel J. Reich
IPO Date
2021-02-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
SAB Biotherapeutics, Inc.
CEO
Samuel J. Reich
IPO Date
2021-02-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US